IMPAX Laboratories, Inc. v. Alza Corporation
3:03-cv-04795
Overview
Parties
Defendant
Alza Corporation NPE (Individual / Inventor)
Represented By
6 Attorneys ListedQuinn Emanuel Urquhart & Sullivan
Quinn Emanuel Urquhart & Sullivan, 50 California Street, 22nd Floor
Office of the District Attorney
County of Santa Clara, 70 West Hedding Street, West Wing
1133 Avenue of the Americas
1133 Avenue of the Americas, New York, NY 10036-2000
Patterson, Belknap, Webb & Tyler LLP
1133 Avenue of the Americas, New York, NY 10036-6710
Patterson, Belknap, Webb & Tyler LLP
1133 Avenue of the Americas, New York, NY 10036-6710
1133 Avenue of the Americas
1133 Avenue of the Americas, New York, NY 10036-6710
Plaintiff
IMPAX Laboratories, Inc. Operating Company
Represented By
4 Attorneys ListedKB Ash Law Group P.C.
2603 Camino Ramon, Suite 200
Goodwin Procter LLP
599 Lexington Avenue, New York, NY 10022
41 West 96th Street, Apt. 7CD
41 West 96th Street, Apt. 7CD, New York, NY 10025
Goodwin Procter LLP
599 Lexington Avenue, New York, NY 10022
Court & Judges
Court
District Court, N.D. California (cand)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 24 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| π°π· South Korea | South Korea Counterpart | View Official Patent → | |
| π°π· South Korea | South Korea Counterpart | View Official Patent → | |
| π©πͺ Germany | Germany Counterpart | View Official Patent → | |
| π¨π¦ Canada | Canada Counterpart | View Official Patent → | |
| π¨π¦ Canada | Canada Counterpart | View Official Patent → | |
| π¨π¦ Canada | Canada Counterpart | View Official Patent → | |
| π¨π¦ Canada | Canada Counterpart | View Official Patent → | |
| π―π΅ Japan | Japan Counterpart | View Official Patent → | |
| π¬π§ United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| π¬π§ United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| π PCT International (WIPO) | PCT World Application | View Official Patent → | |
| π«π· France | France Counterpart | View Official Patent → | |
| π«π· France | France Counterpart | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 4 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5674895
Dosage form comprising oxybutynin
|
Filed: 1995-05-22
Issued: 1997-10-07
|
Expired (Term Ended)
Expires: 2015-05-22
|
|
|
US5840754
Dosage form comprising oxybutynin
|
Filed: 1996-09-05
Issued: 1998-11-24
|
Expired (Term Ended)
Expires: 2016-09-05
|
|
|
US5912268
Dosage form and method for treating incontinence
|
Filed: 1997-02-26
Issued: 1999-06-15
|
Expired (Term Ended)
Expires: 2017-02-26
|
|
|
US6262115
Method for the management of incontinence
|
Filed: 1999-03-29
Issued: 2001-07-17
|
Expired (Term Ended)
Expires: 2019-03-29
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
11
Dispositive
7
Granted
0
Denied
0
Pending / Review
11
Motions by Category
Key Dispositive Motions & Rulings